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Abstract 
 
Based on murine models, the transfusion of natural killer (NK) cell that are derived from bone 
marrow stem cells can augment graft versus leukemia and prevent graft versus host disease; two 
major complications of allogeneic hematopoietic cell transplantation. Additionally, NK cell 
therapy has the benefit of potentially curing leukemia without the toxic side effects of 
chemotherapy. The NK development occurs in the bone marrow and then in the secondary 
lymphoid tissue (lymph nodes). NK cells may be used to target leukemic cells due to the ability 
to recognize and destroy them (Imai, 2005). One of the main obstacles to therapeutic use of NK 
cells is obtaining sufficient numbers to treat patients. We have devised a system to generate NK 
cells from hematopoietic stem cells (HSCs) that result in >2-3,000 fold expansion from a single 
stem cell. This developmental process is dependent on stromal cells and we have identified a 
number of different cell lines that support NK differentiation from HSCs. This research is a 
comparative analysis of differential stromal cell lines which support the NK cell generation from 
HSCs. The main purpose of the work is to compare the AFT, EL, HFWT, OP9, and UG cell lines 
in their ability to induce efficient NK differentiation HSCs. Our results show differences in five 
different cell lines in their ability to support NK development, NK cell counts and the ability to 
destroy leukemic cells. These findings will aid future clinical studies using these cells for 
leukemia treatment.  
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Introduction 
1.1 Natural Killer (NK) cells and subsets 
Natural Killer (NK) cells are lymphoid cells that play vital role in innate immune responses. 
They represent up to ~15 % human peripheral blood mononuclear cells (PBMC) and are defined 
as CD56
+
 CD3
-
 lymphocytes. Peripheral blood NK cells can be separated into two major 
subtypes based on the staining intensity of CD56 and the presence/absence of CD16 (Figure 1). 
More specifically, CD56
bright 
CD16
-
 cells make up a minority of the PB NK cells (~15%) and 
CD56 
dim  
CD16
+
 NK cells make up the majority (~85%) of the NK cells (Gharehbaghian, 2006). 
 
Figure 1. The major differences between human NK CD56
dim
 and CD56
bright 
subsets (Fairclough, 
2008). 
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1.2 NK cell development   
Human NK cells go through a series of development stages outlined in figures 2 and 3. NK cells 
are derived from HSCs and the initial steps of differentiation occur in the bone marrow (BM). 
The steps of differentiation have been broken into five developmental stages of NK cells. Stage I, 
pro-NK cell progenitors have a CD34
+
, CD117
-
, CD94
-
, and CD16
-
 phenotype. The stage I cells 
can be differentiated in to next stage in response to FLT3, IL-3, and IL-7.  In stage II, pre-NK 
cells the cells express two key cytokines receptors CD117 and CD122 and have the functional 
capacity to respond to stem cell factor (SCF) and IL-2 or IL 15, which leads to development into 
stage III.  Stage III NK cells are thought to be “committed” to the NK lineage and have referred 
to immature NK (iNK) cells.  At this step, iNK cells lack all function (cytotoxicity or cytokine 
production).  At stage IV, also known as CD56
bright 
NK cells, they have the ability to make 
cytokines, but lack cytotoxicity. Stage V cells are released from the lymph node and enter the 
blood and are identified by the coexpression of CD16
+ 
and CD94
+  
and are also called CD56
dim 
NK cells These cells have robust cytokine production and cytotoxicity.  The developmental 
system that I used closely resembles these steps (Grzywacz,  2011). .  
 
 
Figure 2. Model of human NK-cell development. Bone marrow – derived CD34+ 
HPCs
+
CD45RA
+
 circulate (Caligiuri, 2008). 
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Figure 3. NK cell subsets, model of human CD56 NK-cell differentiation (Moretta, 2010). 
 
1.3 NK Cell triggering and inhibitory receptors 
NK cells can recognize aberrant cells and have the ability to kill them and also produce cytokines, 
such as interferon gamma (IFN-). In addition to recognizing tumor cells, NK cells also 
recognize virally infected cells (Mickel, 1988). NK cells recognize deranged cells due to the loss 
of MHC class I or the expression of “stress receptors” not normally expressed by healthy cells. 
NK cells recognize these cells using a variety of receptors that both activate and inhibit NK cell 
function, including Killer Ig receptors (KIR), NKG2D, DNAM-1, 2B4, NKp30 (Ahn, 2010; 
Vacca, 2008). Upon encounter with a potential target cells these receptors become engaged and it 
is the balance of signaling that determines whether the NK cells is activated. NK cells also 
become activated when cytokines are present including, IFN-γ and tumor necrosis factor-alpha 
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(TNF-α). As well, NK cells produce a number of cytokines including interleukin10 (IL-10), 
granulocyte macrophage-colony stimulating factor (GM-CSF), and tumor necrosis factor-beta 
(TNF-β) (Moretta A., Morretta L, 2004). 
 
1.4 Goal of Research  
One of the main limitations to the clinical use of NK cells is obtaining sufficient numbers to treat 
patients. We have previously found that a number of different cell lines support the development 
of HSCs into the NK lineage, in the presence of cytokines. The goal of this project was to 
compare these lines in their ability to give rise to NK cells. We also sought to compare the 
function of these NK cells developed under the influence of the different stromal lines.  
 
2. Materials and Methods 
2.1 Primary human CD 34
+
 cells isolated from umbilical cord blood (UCB) 
UCB was obtained after vaginal and cesarean deliveries and by drainage of blood into sterile 
collection tubes that have the anticoagulant citrate-phosphate-dextrose. All cord blood specimens 
were obtained from New York Blood center on IRB approved protocols. UCB samples were 
processed within 48 hours of collection. CB mononuclear cells (MNCs) include rare 
hematopoietic stem cells (~1%). CD34
+
 cells were isolated from CB using positive immune-
magnetic bead separation techniques (Miltenvi biotech). Selected cells were about 90% pure by 
FACS analysis.    
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2.2 Cell Culture of the Wilms’ tumor cell line, HFWT  
The human Wilms’ tumor cell line, HFWT was taken from - 0  C li uid nitrogen tank. Ham’s 
F12 media was used to maintain the HFWT cell line. The media was made before the start of 
HFWT cell culture, Ham’s F12 with 15% fetal bovine serum (FBS) was used to make a 
supplement for HFWT cell culture. HFWT was cultured on gelatin coated 75ml flasks. HFWT 
cells are incubated at 3   C with humidified atmosphere of 5% CO2. HFWT was split into 24 
well plate and incubated prior to use. When it was fully confluent, HFWT cells were irradiated at 
3,000 rads (Harada, 2004). 
 
2.3 Culture of the stromal cell line OP9 
Murine OP9 bone marrow stromal cells, was taken from - 0  C li uid nitrogen tank and thawed 
using standard techniques. These cells were cultured alpha ( -MEM) media with L-glutamine, 
2.2g of sodium bicarbonate,  -mercaptoethanol, and penicillin/streptomycin solution. OP9 was 
cultured at 37  C and 5% CO2f in incubator. When it was fully confluent, OP9 was split into 24 
well plate and incubated prior to use and then irradiated at 3,000 rads (Saito, 2013). 
 
2.4 Culture of the stromal cell line AFT-204 
AFT-204 is the immortalized murine fetal liver stromal cell line. The media used to culture these 
cells was Dulbecco’s modified Eagles’s medium (DMEM) with 10 % heat-inactivated of fetal 
bovine serum (FBS),  -mercaptoethanol (50  M/L), L-glutamine, penicillin/streptomycin, 
streptomycin, and hydrocortisone solution were used to maintain the AFT-204 cells. As above, 
AFT-204 cells were grown to confluence and irradiated at doses of 3,000 rads before use.  
14 
 
 
2.5 Culture of the stromal cell line EL   
The murine embryonic liver cell line, EL media used Alpha ( -MEM) media with 7.5% fetal 
bovine serum (FBS), 50% myelocult (M5300, glutamax (2mM),  -mercaptoethanol (50 M/L), 
hydrocortisone (10
-6
), and penicillin/streptomycin solution were used to maintain the EL cell 
line. To co-culture with progenitor cells, EL cells were irradiated at doses of 3,000 rads.  
 
2.6 Culture of the stromal cell line UG 
UG is a murine embryonic liver cell line. UG media used Alpha ( -MEM) media with 7.5% fetal 
bovine serum (FBS), 50% myelocult (M5300, glutamax (2mM),  -mercaptoethanol (50 M/L), 
hydrocortisone (10
-6
), and penicillin/streptomycin solution were used to maintain the EL cell 
line. To co-culture with progenitor cells, EL cells were irradiated at doses of 3,000 rads.  
 
2.7 Fluorescence Activated Cell Sorting (FACS)  
Fluorescence activated cell sorting (FACS) was used to determine the percentage of NK cells in 
culture. Cells were isolated from cultures and stained with CD56 antibodies and analyzed using a 
FACScanto. The percentage of NK cells was determined using Flowjo software.  
 
2.8 Differentiation of CD34+ cells into NK cells  
In lymphocyte development and homeostasis, cytokines play a vital role and various mixtures 
have been used to generate human NK cells. Cytokines play critical roles in regulating aspects of 
immune responses. CD34
+
 HPC in vitro were cultured on irradiated stroma (above) in media 
containing IL-3, IL-7, IL-15, SCF, and FLT3. Cultures were refreshed by removing 50% of the 
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culture media and adding new cytokines twice weekly starting at D+14.  Cells were analyzed on 
D28 of culture. 
 
2.9 Cytotoxicity assay (Chromium-51 (
51
Cr) Release Assay) 
K562 erythroleukemia cell line targets were used in killing assays. K562 targets were labeled 
with 
51
Cr by incubating 1 x 10
6
 cells in 11.1 MBq, 
51 Cr for 2 hours at 3   C. 5% CO2   (Schmidt, 
2004).  The cells were washed with PBS and resuspended in RPMI with 10% FBS. Plated in 96 
well plates at 1 x 10
4
 cells/well in triplicate. Incubated for 4 hours at 3   C, 5% CO2 (Grzywacz, 
2011).  
 
Figure 4. Principle of chromium release assay. 51Cr labeling the target cell, cytolysis the labeled 
51Cr, and detection of the released 51Cr label, these are 3 main steps of the procedure (Schmidt, 
2004). 
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% cytotoxicity = 
                                                         
                                   
 
 
3.0 Results 
3.1 Comparison of the five different stromal cells and their ability to support NK 
development 
CB CD34
+ 
cells were obtained from healthy human donors UCBs and were expanded from day 0 
to day 28 of culture (as described in the methods section) using the following stromal cell lines:  
EL, AFT, UG, OP9 and HFWT.  Controls included cultured in cytokines without stroma. 
 
 
17 
 
 
Figure 5. Impact of different stromal cells on the percentage of NK cells (defined as CD56
+
) in 
culture over time. CD34
+
 cells were cultured on the different irradiated stromal cells and the 
percentage of NK cells were assessed over time. Shown is the data from the donors. 
 
The first experiment focused on exploring the NK cell yield from two separate donors using 
different feeder cell lines. I performed experiments comparing the AFT, EL, UG cell lines. As 
shown in figure 5, the percentage of CD56 
+ 
cells starts to rise dramatically, starting at D14. By 
Day 21 the percentage of CD56
+ 
were relatively low for all conditions and seemed to not differ 
for the AFT, EL, UG cell lines or the no stroma control. Interestingly, HFWT and OP9 cell lines 
did not appear to support NK cells and are not shown. By day 28 both donors showed significant 
NK development, with the majority of the cells in culture being NK cells. For donor 1, there 
18 
 
appeared to be no differences between the conditions, while for donor 2 the results suggested 
more NK cell development in EL and AFT supported cultures. 
   
 
 
3.2 Determination of the function of HSC-derived NK cells 
Figure 6 shows the results of a killing assay where HSC-derived NK cells are used to kill 
51
Cr 
labelled target cells. At day 21 the cytotoxicity was basically the same for each condition. On the 
other hand at day 28 the NK cells derived from either AFT or EL stromal lines retained their 
function, but those derived in the presence of UG (for donor 2) or no stroma lost cytotoxic 
activity.  
 
 
Figure 6. Cytotoxicity of NK cells generated on Different Stromal cell lines at Day 21 and Day 
28 of culture. Shown are the results of cytotoxicity assays of HSC-derived NK cells generated on 
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the various stromal cell lines. Target cells were K562 and effector to targets ratios are show in 
the legend. The results for two donors at D21 and D28 are shown. 
 
3.3 IL-22 Production at D21 
Recently, our laboratory has shown that a unique population of NK cells differentiates in these 
cultures. These cells, which were originally called NK-22, have been more recently renamed as 
group 3 innate lymphoid cells. Unlike all other NK cells, these cells are characterized by high 
production of IL-22 upon stimulation with IL-1   and IL-23. To test whether these cells 
differentiate under the influence of various stromal cells the expanded cells were stimulated with 
the above cytokines and supernatant was assessed for IL-22 by ELISA. As shown in figure 7, IL-
22 could be detected in both donors, but at differing concentrations depending upon the stromal 
cell line and the donor used. The concentrations varied between the donors, making it impossible 
to know whether the differences were due to the stromal cell lines or genetic differences in the 
donors. 
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Figure 7. Day 21 ELISA for IL-22. 1x10
6
 cells were collected from cultures at D21 and 
stimulate with IL-1β and IL-23 and supernatant was collected 16 hours later. Shown are the 
supernatant of cells in culture ad D21 (“bulk”), after isolation but without stimulation (“unstim”) 
and after stimulation with IL-1β and IL-23 (“stim”). Listed on the x-axis are the stromal cell 
lines used to create the NK cells.) 
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Discussion 
 
This project examines the influence of five different stromal cell lines on the generation of NK 
cells from HSCs. From these studies, we observed that the cell lines HFWT and OP9 do not 
support the growth of NK cells from human CB CD34
+
 cells. In contrast, AFT-024, EL, UG all 
support NK cell development and expansion.  There were no clear differences noted in these 
latter stromal lines; with considerable donor to donor variation, which is common in human 
research.  
 
In previous research, the Verneris’ laboratory has demonstrated the necessity of stromal support 
in the differentiation of CD34
+
lin
-
 cells into NK cells. However the mechanism by which stromal 
cells mediate this activity has not been elucidated and is unknown. We speculate that the fetal 
stromal ells express surface receptors (or cytokines) that drive lymphopoiesis and NK 
differentiation, but the exact receptors involved in this process are unknown. Other investigators 
have used heparin in place of stroma to generate large numbers of NK cells. These studies show 
that large amounts of highly active NK cells can be produced in a closed system and under 
feeder free conditions, which is a benefit since regulatory approval will be much easier to obtain 
(Spanholtz, 2011). The mechanism of this approach is thought to be through the binding of 
heparin to cytokines and the presentation these cytokines to HSCs. As well, heparin may protect 
the cytokines from degradation.  Our laboratory has recently compared the heparin-based method 
to the stromal-based method NK generation and found that both give rise to NK cells, but that 
the stromal-based method results in numerically more NK cells that are more mature (Dezell, 
2012). While both methods generate clinical grade NK cells, the stromal method will require 
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significantly more regulatory oversight compared to the heparin method. Thus, it could be 
argued as to which approach is best for clinical translation.  
 
Over the course of this research, I tested five different cell lines for their ability to support NK 
differentiation form HSC. While the AFT, EL, UG supported NK development, the OP9 and 
HFWT cell lines did not. Prior studies have shown that OP9 can support human NK 
differentiation (Beck, 2009), perhaps suggesting technical difficulties in our studies. The fact that 
HFWT is not a stromal cell line, but rather a cancer cell line makes it different from the other 
cells used in this study and may explain why it did not support NK development from CD34+ 
cells. Interestingly, HFWT does support the dramatic grown, expansion and activation of mature 
NK cells (Harada 2004). While this research did not identify a clearly superior stromal cell line 
for NK generation from HSC, these studies do further support the idea that HSCs can be 
differentiated into NK cells possibly for clinical use.  
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